skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

ALL-CAUSE MORTALITY ANALYSIS OF THE PROTECT-AF AND PREVAIL STUDIES OF LEFT ATRIAL APPENDAGE CLOSURE

Journal of the American College of Cardiology, 2018-03, Vol.71 (11), p.A401-A401 [Peer Reviewed Journal]

2018 American College of Cardiology Foundation ;Copyright Elsevier Limited Mar 10, 2018 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/S0735-1097(18)30942-2

Full text available

Citations Cited by
  • Title:
    ALL-CAUSE MORTALITY ANALYSIS OF THE PROTECT-AF AND PREVAIL STUDIES OF LEFT ATRIAL APPENDAGE CLOSURE
  • Author: Whang, William ; Holmes, David ; Miller, Marc ; Langan, Marie-Noelle ; Choudry, Subbarao ; Sofi, Aamir ; Koruth, Jacob ; Dukkipati, Srinivas ; Reddy, Vivek Yerrapu
  • Subjects: Health risk assessment ; Mortality
  • Is Part Of: Journal of the American College of Cardiology, 2018-03, Vol.71 (11), p.A401-A401
  • Description: Background Compared with warfarin, left atrial appendage closure (LAAC) reduced hemorrhagic stroke and cardiovascular mortality in a patient-level meta-analysis of the PROTECT-AF and PREVAIL trials. Conclusion Despite the competing risks of mortality in this elderly cohort, this analysis of 5-year mortality using updated vital status data from PROTECT-AF and PREVAIL revealed that LAAC with Watchman was associated with a 30% improved survival compared with warfarin.
  • Publisher: New York: Elsevier Inc
  • Language: English
  • Identifier: ISSN: 0735-1097
    EISSN: 1558-3597
    DOI: 10.1016/S0735-1097(18)30942-2
  • Source: Geneva Foundation Free Medical Journals at publisher websites
    Alma/SFX Local Collection

Searching Remote Databases, Please Wait